Biological mechanisms of dopamine D2-like receptor agonist therapy in diabetes

Biological mechanisms of dopamine D2-like receptor agonist therapy in diabetes

Saved in:

Bibliographic Details
Main Authors:	Zachary Freyberg, Ronald A. Codario
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Endocrinology
Subjects:	dopamine D2-like receptors diabetes dysglycemia central nervous system pancreas
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1532414/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disease-Associated Dopamine Receptor D2 Variants Exhibit Functional Consequences Depending on Different Heterotrimeric G-Protein Subunit Combinations
by: Nele Niebrügge, et al.
Published: (2024-12-01)

Associations between inflammation and striatal dopamine D2-receptor availability in aging
by: Vanessa Crine, et al.
Published: (2025-01-01)

Synaptic enrichment and dynamic regulation of the two opposing dopamine receptors within the same neurons
by: Shun Hiramatsu, et al.
Published: (2025-01-01)

T-2 toxin triggers depression-like behaviors via upregulation of dopamine transporter in nucleus accumbens of male mice
by: Zhigang Chen, et al.
Published: (2025-01-01)

One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists
by: Hirotaka Watada
Published: (2025-02-01)

MICRO DETERMINATION OF DOPAMINE IN BIOLOGICAL SAMPLES BY COUPLING REACTION
by: AHMED JASSIM MUKLIVE AL-OGAIDI
Published: (2016-12-01)

Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01)

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)

A RESEARCH ON SOCIAL MEDIA ADDICTION AND DOPAMINE DRIVEN FEEDBACK
by: Gamze Macit, et al.
Published: (2018-12-01)

Efficacy and safety of glucagon-like peptide-1 receptor agonists in the elderly versus non-elderly patients with type 2 diabetes mellitus: insights from a systematic review
by: Yao Wang, et al.
Published: (2024-06-01)

Dopamine receptors and key elements of the neurotrophins (BDNF, CDNF) expression patterns during critical periods of ontogenesis in the brain structures of mice with autism-like behavior (BTBR) or its absence (С57BL/6J)
by: P. D. Pravikova, et al.
Published: (2024-07-01)

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma
by: Angela J. Yoon, et al.
Published: (2025-01-01)

Acid sphingomyelinase modulates anxiety-like behavior likely through toll-like receptor signaling pathway
by: Huiqi Yuan, et al.
Published: (2025-02-01)

Association of dopamine receptor D2 -141C insertion/deletion and dopamine beta-hydroxylase 19 bp insertion/deletion polymorphisms with schizophrenia: A case-control study in the eastern Algerian population
by: Boukhenaf Yasmina, et al.
Published: (2024-01-01)

Significant abundance of bacterial flagellin and expression of its surface localized receptor toll-like receptor 5 and cytokine interleukin-22 in South African infants with poor oral rotavirus vaccine take
by: Nontlantla J. Haindongo, et al.
Published: (2025-01-01)

Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
by: Ahmad Vafaeian, et al.
Published: (2025-02-01)

Exploring the impact of deleterious missense nonsynonymous single nucleotide polymorphisms in the DRD4 gene using computational approaches
by: Dipto Kumer Sarker, et al.
Published: (2025-01-01)

Colorimetric Detection of Dopamine Based on Peroxidase-like Activity of β-CD Functionalized AuNPs
by: Sara Anderson, et al.
Published: (2025-01-01)

High fructose rewires gut glucose sensing via glucagon-like peptide 2 to impair metabolic regulation in mice
by: Eya Sellami, et al.
Published: (2025-03-01)

An Electrochemical Dopamine Assay with Cobalt Oxide Palatinose Carbon Dots
by: Ram Chandra Nepal, et al.
Published: (2025-01-01)

Enhanced renoprotective effects of combined glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Real‐world evidence
by: Jian‐Yu Jhu, et al.
Published: (2025-02-01)

Theoretical study on the conformation-dependent charge transfer of the excited state of dopamine
by: Huan An, et al.
Published: (2025-01-01)

Functional state of the nigrostriatal system of Krushinsky – Molodkina rats during audiogenic seizure expression
by: N. A. Dorofeeva, et al.
Published: (2016-05-01)

The Neurometabolic Function of the Dopamine–Aminotransferase System
by: Sergey A. Apryatin
Published: (2025-01-01)

Electrochemical Detection of Dopamine with Graphene Oxide Carbon Dots Modified Electrodes
by: Omar Isaac Torres-Soto, et al.
Published: (2025-01-01)

Revealing the biological features of the axolotl pancreas as a new research model
by: Hui Ma, et al.
Published: (2025-01-01)

Transcriptomic and behavioral studies reveal that glutamate receptors are involved in depressive-like behavior in adult olive flounder Paralichthys olivaceus
by: Liangfang Liu, et al.
Published: (2025-01-01)

Extracellular vimentin is a damage-associated molecular pattern protein serving as an agonist of TLR4 in human neutrophils
by: Łukasz Suprewicz, et al.
Published: (2025-02-01)

Polymorphic variants of the dopamine receptor gene <i>DRD2</i> (rs6277, rs1800497) in adolescents with problematic video game use
by: S. Yu. Tereshchenko, et al.
Published: (2024-10-01)

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β‐Klotho‐Mediated Ferroptosis Inhibition
by: Shasha Tian, et al.
Published: (2025-01-01)

Predictors of biochemical and structural response to medical therapy in patients with active acromegaly following surgery: a real-world perspective
by: Maryam Rafieemanesh, et al.
Published: (2025-02-01)

Exogenous dopamine application ameliorates chilling injury and preserves quality of kiwifruit during cold storage
by: Morteza Soleimani Aghdam, et al.
Published: (2025-01-01)

The Impact of Selected Regimens of Chronic HIV‐Antiretroviral Treatment on Glycemic Control Markers and Correlates: A Systematic Review and Meta‐Analysis Protocol
by: Mlindeli Gamede, et al.
Published: (2025-01-01)

Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01)

Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes
by: Bethany Murphy, et al.
Published: (2025-01-01)

Toll-like receptor upregulation in liver and peripheral blood mononuclear cells of patients with amoebic liver abscess
by: Sandhya Khunger, et al.
Published: (2025-03-01)

Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
by: Alexander C. Martins, et al.
Published: (2024-04-01)

Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: historical development and future challenges
by: Francisco Westermeier, et al.
Published: (2025-01-01)

Effect of Grovth Medium on L-Dopa and Dopamine Production Using Citrobacter freundii (NRRL B-2643)
by: Sinan Saydam, et al.
Published: (2022-12-01)

Association of Low-Attenuation Plaque with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus in Patients with Suspected Coronary Artery Disease
by: Thomas R. Andersen, et al.
Published: (2024-12-01)